Join NCPA and experts from CMS and Beacon MFP on April 7 at 3 p.m. ET for updates on the Medicare Prescription Drug Price Negotiation Program, the Medicare Transaction Facilitator, and Maximum Fair Price refund payments. Following the updates, NCPA will facilitate a Q&A session for issues lingering from the first quarter of 2026 and looking ahead to the drugs selected for 2027 and the addition of Part B drugs in 2028. Register in advance to submit your questions.
NCPA
